Trial · NCT02249702
Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma
NCT02249702, Phase 2, Completed, Mario Negri Institute for Pharmacological Research
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma. Trials, record NCT02249702. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02249702
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma
- NCT number
- NCT02249702
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 168 participants, actual
- Lead sponsor
- Mario Negri Institute for Pharmacological Research
- Conditions
- Leiomyosarcoma
- Interventions
- gemcitabine + docetaxel, trabectedin
- First posted
- 2014-09-25
- Last updated
- 2017-12-06
- Other registries' IDs
- eudract:2009-016017-24
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | progression free rate at 6-month | 6-month | Primary objective will be to assess the clinical benefit rate (defined as 6-month progression free rate) with trabectedin in patients with locally relapsed/metastatic uterine leiomyosarcoma pretreated with anthracycline ± ifosfamide and/or gemcitabine ± docetaxel. |
| Secondary | best response rate | within 6 months | response rate according to RECIST v1.0 criteria |
| Other | progression free survival | 24 months | Time from inclusion into the study to progression or death whichever comes first |
| Other | Overall survival | 24 months | time from inclusion into the study to death from any cause |
| Other | safety profile | up to 30 days after the end of treatments | Number of Patients with Serious and Non-Serious Adverse Events |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02249702
GET https://conductscience.org/api/trials/v1/NCT02249702/registered